Viewing nowCombinationEmpogad Duo Tablet 5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 202201365 · Approved 2022.04.04 · Insurance code 651206220
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to help control blood sugar in adults with type 2 diabetes in combination with empagliflozin and metformin. It is designed to effectively manage blood sugar when administered alongside dietary and exercise therapy. Special care should be taken in adults with type 2 diabetes who have cardiovascular disease, as they may require additional guidance from a healthcare professional due to the risk of cardiovascular events. Overall, this medication is used to improve blood sugar control.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined according to each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients taking this medicine who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered as this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Cautious Administration, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication helps in controlling blood sugar levels. However, it should not be used in patients with poor kidney function, acute infections, dehydration, or heart problems. Pregnant or nursing women should also avoid using this medication. This medication may cause hypoglycemia; therefore, special caution is needed when used in conjunction with insulin or other hypoglycemic agents. Furthermore, there is a risk of serious side effects such as lactic acidosis; if symptoms such as sudden muscle pain, difficulty breathing, or weakness occur, consult a doctor immediately. Regular monitoring of kidney function is necessary during the course of this medication, and discontinuation is required if kidney function deteriorates rapidly. Urinary tract infections or genital infections may occur; seek prompt treatment if any related symptoms appear. For surgeries or imaging with contrast, this medication should be paused for a period, and it should only be resumed after confirming normal kidney function. Elderly patients or those at risk of fluid loss must be cautious of dehydration and hypotension, requiring adequate hydration. This medication can lower vitamin B12 levels, so it is advisable to have vitamin B12 checks if taken long-term. Alcohol consumption may increase the risk of side effects from this medication, so it is recommended to avoid it. Finally, this medication is not recommended for children, and any abnormal symptoms while taking it should be reported to healthcare professionals immediately.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to keep the storage temperature between 1 and 30 degrees Celsius at room temperature.
Orange-yellow biconvex oval film-coated tablet
For domestic use - 10 tablets/box[(10 tablets/PTP x 1)], For domestic use - 60 tablets/box[(10 tablets/PTP x 6)], For domestic use - 30 tablets/bottle, For domestic use - 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.